Advanced Cancer
Showing NaN - NaN of 45
Squamous Cell Carcinoma of Head and Neck, NSCLC, Hepatocellular Carcinoma Trial in Worldwide (KY1044, KY1044 and atezolizumab)
Recruiting
- Squamous Cell Carcinoma of Head and Neck
- +11 more
- KY1044
- KY1044 and atezolizumab
-
New Haven, Connecticut
- +12 more
Nov 3, 2022
Tumors, Metastatic Cancer, Advanced Cancer Trial in United States (Niraparib, TSR-042, Carboplatin-Paclitaxel)
Biliary Tract Cancer, Metastatic Cancer, Advanced Cancer Trial in Worldwide (Ramucirumab, Merestinib, Cisplatin)
Active, not recruiting
- Biliary Tract Cancer
- +2 more
- Ramucirumab
- +5 more
-
Tucson, Arizona
- +91 more
Oct 18, 2022
Advanced Cancer, Relapsed Cancer, Refractory Cancer Trial in Nashville (Animal-Assisted Interactions)
Recruiting
- Advanced Cancer
- +2 more
- Animal-Assisted Interactions
-
Nashville, TennesseeMonroe Carell Jr Children's Hospital at Vanderbilt
May 9, 2022
Bladder Cancer, Urothelial Carcinoma, Solid Tumor Trial in Worldwide (IPI-549 (eganelisib), Nivolumab, Placebos)
Active, not recruiting
- Bladder Cancer
- +3 more
- IPI-549 (eganelisib)
- +2 more
-
Fort Wayne, Indiana
- +28 more
Apr 1, 2022
Carcinoma, Endometrial Adenocarcinoma, Tumors Trial in United States (PEN-866 Sodium, fluorouracil, Folinic acid)
Recruiting
- Carcinoma
- +18 more
- PEN-866 Sodium
- +3 more
-
Springdale, Arkansas
- +15 more
Feb 16, 2022
Urothelial Carcinoma, Urothelial Carcinoma Bladder, Bladder Cancer Trial in United States (IK-175, IK-175 and nivolumab)
Recruiting
- Urothelial Carcinoma
- +20 more
- IK-175
- IK-175 and nivolumab
-
Gilbert, Arizona
- +9 more
Feb 3, 2022
Advanced Cancer, Ovarian Cancer, Breast Cancer Trial in United States (COM701, COM701 with Opdivo (Nivolumab).)
Recruiting
- Advanced Cancer
- +9 more
- COM701
- COM701 with Opdivo (Nivolumab).
-
Los Angeles, California
- +10 more
Jan 25, 2022
Advanced Cancer, Relapsed Cancer, Refractory Cancer Trial in Nashville (Animal-Assisted Interactions)
Active, not recruiting
- Advanced Cancer
- +2 more
- Animal-Assisted Interactions
-
Nashville, TennesseeMonroe Carell Jr Children's Hospital at Vanderbilt
Jan 18, 2022
Advanced Cancer, Metastatic Melanoma, Metastatic NSCLC Trial in Worldwide (LY3214996, Midazolam, Abemaciclib)
Active, not recruiting
- Advanced Cancer
- +3 more
- LY3214996
- +6 more
-
Washington, District of Columbia
- +12 more
Sep 2, 2021
Advanced Cancer Trial in United States (Mocetinostat - 50 mg, Mocetinostat - 70 mg, Mocetinostat - 90 mg)
Terminated
- Advanced Cancer
- Mocetinostat - 50 mg
- +4 more
-
Mobile, Alabama
- +14 more
Mar 10, 2021
Advanced Cancer, Gastric Adenocarcinoma, Gastroesophageal Junction Adenocarcinoma Trial in Boston, New York, Nashville
Completed
- Advanced Cancer
- +5 more
-
Boston, Massachusetts
- +3 more
Nov 24, 2020